317 results on '"Mouillac, Bernard"'
Search Results
2. Biased activation of the vasopressin V2 receptor probed by molecular dynamics simulations, NMR and pharmacological studies
3. Structures of the arginine-vasopressin and oxytocin receptor signaling complexes
4. G protein peptidomimetics reveal allosteric effects and stepwise interactions in ghrelin receptor–G protein coupling.
5. Structural characterization of the active and inactive conformations of the vasopressin V2 receptor using cryo-EM
6. The ligand-bound state of a G protein-coupled receptor stabilizes the interaction of functional cholesterol molecules
7. Fluorescent-Based Strategies to Investigate G Protein-Coupled Receptors: Evolution of the Techniques to a Better Understanding
8. Biased Agonist Pharmacochaperones: Small Molecules in the Toolbox for Selectively Modulating GPCR Activity
9. Chapter Seven - Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics
10. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors
11. Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease
12. Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4H-pyran core: Switch from antagonist to agonist effect by chemical modification
13. Bringing GPCR Structural Biology to Medical Applications: Insights from Both V2 Vasopressin and Mu-Opioid Receptors
14. Biased activation of the vasopressin V2 receptor probed by NMR, paramagnetic ligands, and molecular dynamics simulations
15. Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics
16. Time-Resolved FRET-Based Assays to Characterize G Protein-Coupled Receptor Hetero-oligomer Pharmacology
17. The Concise Guide to PHARMACOLOGY 2023/24 : G protein-coupled receptors
18. The Concise Guide to PHARMACOLOGY 2023/24:G protein-coupled receptors
19. Vasopressin and oxytocin receptors in GtoPdb v.2023.1
20. Vasopressin receptors and pharmacological chaperones: From functional rescue to promising therapeutic strategies
21. Ghrelin receptor conformational dynamics regulate the transition from a preassembled to an active receptor : Gq complex
22. Chapter Three - Structures of the arginine-vasopressin and oxytocin receptor signaling complexes
23. Structure of the vasopressin hormone–V2 receptor–β-arrestin1 ternary complex
24. Heterodimerization with Its Splice Variant Blocks the Ghrelin Receptor 1a in a Non-signaling Conformation: A STUDY WITH A PURIFIED HETERODIMER ASSEMBLED INTO LIPID DISCS*
25. V1b vasopressin receptor trafficking and signaling: Role of arrestins, G proteins and Src kinase
26. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors
27. Biased Agonist Pharmacochaperones: Small Molecules in the Toolbox for Selectively Modulating GPCR Activity
28. Fluorescent-Based Strategies to Investigate G Protein-Coupled Receptors: Evolution of the Techniques to a Better Understanding
29. Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling
30. Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy
31. Expression, purification and NMR characterization of the cyclic recombinant form of the third intracellular loop of the vasopressin type 2 receptor
32. New advances in production and functional folding of G-protein-coupled receptors
33. Amphipols in G Protein-Coupled Receptor Pharmacology: What Are They Good For?
34. Leukotriene BLT2 Receptor Monomers Activate the Gi2 GTP-binding Protein More Efficiently than Dimers
35. A new Kunitz‐type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor
36. Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones
37. Structure of the Third Intracellular Loop of the Vasopressin V2 Receptor and Conformational Changes upon Binding to gC1qR
38. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
39. The multifunctional protein GC1q-R interacts specifically with the i3 loop arginine cluster of the vasopressin V 2 receptor
40. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents
41. Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity
42. A new Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor.
43. Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity
44. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22:G protein-coupled receptors
45. The two NK-1 binding sites correspond to distinct, independent, and non-interconvertible receptor conformational states as confirmed by plasmon-waveguide resonance spectroscopy
46. Cryo–electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex
47. Time Resolved FRET Strategy with Fluorescent Ligands to Analyze Receptor Interactions in Native Tissues: Application to GPCR Oligomerization
48. Molecular pharmacology of vasopressin receptors
49. Mammalian Membrane Receptors Expression as Inclusion Bodies in Escherichia coli
50. TR-FRET Between Engineered Nanobodies Reveals Existence of Endogenous CXCR4 Oligomers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.